2021
DOI: 10.21203/rs.3.rs-438628/v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Repurposing NASVAC, a hepatitis B therapeutic vaccine, for pre- and postexposure prophylaxis of SARS-CoV-2 infection

Abstract: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the subsequent coronavirus 2019 (COVID-19) have led to tens of millions of cases and millions of deaths around the world. Although more than a year has passed since the emergence of COVID-19, more waves of the pandemic, with new variants of the deadly virus, have been reported. It seems that the virus will continue to infect people for years or decades to come and thus lead to more illnesses and deaths. The experiences last year regarding limitin… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

1
0
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 30 publications
1
0
0
Order By: Relevance
“…Our data shows that HBc VLPs stimulation can lead to obvious upregulation of the B cell surface markers CD40 and CD86 but the negligible level of CD40, which is due to the high basic expression level of CD40 on the B cell surface and is similar to the report from Lobaina et al [ 29 ]. Furthermore, the cytokine secretion (IL-12 and IFN-γ) of antigen-presenting cells (APCs) following stimulation is consistent with prior findings showing the production of inflammatory cytokines was increased in volunteers’ peripheral blood mononuclear cells and DCs one day after HBc VLPs treatment [ 25 , 40 ].…”
Section: Discussionsupporting
confidence: 89%
“…Our data shows that HBc VLPs stimulation can lead to obvious upregulation of the B cell surface markers CD40 and CD86 but the negligible level of CD40, which is due to the high basic expression level of CD40 on the B cell surface and is similar to the report from Lobaina et al [ 29 ]. Furthermore, the cytokine secretion (IL-12 and IFN-γ) of antigen-presenting cells (APCs) following stimulation is consistent with prior findings showing the production of inflammatory cytokines was increased in volunteers’ peripheral blood mononuclear cells and DCs one day after HBc VLPs treatment [ 25 , 40 ].…”
Section: Discussionsupporting
confidence: 89%